ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Estrella Immunopharma, Inc.
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.38−0.05 (-11.65%)
Close on Oct 19, 2026
- Market cap
- $16.17M
- P/E (TTM)
- –
- Dividend yield
- –
Estrella Immunopharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Market Cap | $16.52M | $166.30M |
| Enterprise Value | $16.42M | $88.19M |
Income (trailing twelve months)
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Operating Income | -$7.31M | -$21.40M |
| Pretax Income | -$7.31M | -$14.34M |
| Net Income | -$7.31M | -$22.46M |
| EBITDA | -$7.31M | -$16.91M |
| EPS (Diluted) | -$0.27 | -$0.83 |
Returns
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Return on Assets (ROA) | -400.7% | -40.9% |
Balance sheet
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $100.00K | $61.43M |
| Net Cash (Debt) | $100.00K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$7.43M | $49.09M |
| Book Value Per Share | -$0.17 | $1.37 |
| Tangible Book Value | -$7.43M | $23.52M |
| Working Capital | -$7.43M | $76.81M |
Financial position
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Current Ratio | 0.20 | 3.34 |
| Quick Ratio | 0.01 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.07M | -$12.35M |
Efficiency
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Profits Per Employee | -$15.46K | -$703.34K |
| Employee Count | 473 | 74 |
Dividends and yields
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Earnings Yield | -44.2% | -23.3% |
| Buyback Yield | 2.14% | -0.59% |
| Shareholder Yield | 2.14% | 0.00% |
Shares
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Shares Outstanding | 43,497,900 | 58,127,000 |
| Float | 42,718,200 | 49,136,700 |
| Shares Held by Insiders | 1.79% | 11.6% |
| Shares Held by Institutions | 12.0% | 59.4% |
Taxes
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Income Tax | $1.63K | $79.87K |
Scores
| Measure | Estrella Immunopharma | Industry median |
|---|---|---|
| Altman Z-Score | -48.95 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Estrella Immunopharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.